Navigation Links
Acura and King Receive FDA Complete Response Letter Regarding Acurox(R)
Date:7/2/2009

ssolved tablets and nasal snorting of crushed tablets. The Acurox(R) Tablets NDA was originally accepted for filing by FDA earlier this year with a priority review classification.

About Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in research, development and manufacture of Aversion(R) (abuse deterrent) Technology product candidates and other innovative abuse deterrent technologies. Acura and King jointly developed Acurox(R) Tablets and are developing three additional opioid analgesic product candidates utilizing Aversion(R) Technology pursuant to a 2007 License, Development and Commercialization Agreement.

About King Pharmaceuticals, Inc.

King, headquartered in Bristol, Tennessee, is a vertically integrated branded pharmaceutical company. King, an S&P 500 Index company, seeks to capitalize on opportunities in the pharmaceutical industry through the development, including through in-licensing arrangements and acquisitions, of novel branded prescription pharmaceutical products and technologies that complement the Company's focus in specialty-driven markets, particularly neuroscience and hospital. King's wholly-owned subsidiary, Alpharma, Inc., is also a leader in the development, registration, manufacturing and marketing of pharmaceutical products for food producing animals.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"). When used in this press release, the words "estimate," "project," "anticipate," "expect," "intend," "believe," and similar expressions are intended to identify forward-looking statements. Examples of forward looking statements in this press release include statements concerning the Companies' expectations regarding the timing or content of their response to the FDA conc
'/>"/>

SOURCE King Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
2. Takeda Receives FDA Complete Response Letter for Alogliptin, an Investigational Treatment for Type 2 Diabetes
3. SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
4. Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM)
5. Cepheid Receives Grant to Develop Ten-Color Real-Time PCR Detection Technology for Use in the GeneXpert(R) System
6. DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec(R) in GI GVHD
7. Malaria Vaccine Developer, Sanaria Inc., Receives 2009 Vaccine Industry Excellence Award for Best Early-Stage Vaccine Biotech
8. NeurogesX Receives FDA Orphan Drug Designation for Qutenza(TM) for Treatment of Postherpetic Neuralgia
9. AMT Receives EMEA Orphan Drug Designation for Acute Intermittent Porphyria
10. Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System
11. Agennix Receives Fast Track Designation From FDA for Talactoferrin in Combination With Sunitinib for Renal Cell Carcinoma

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... 2 Reportlinker.com announces that...catalogue: ,, Pharmaceutical Contract Manufac....reportlinker.com/p0164248/Pharmaceutical-Contract..., Global pharma industry faces numerous challenges...markets, rising cost of new product development, d...
(Date:12/2/2009)...2 Reportlinker.com announces that ...atalogue: ,, Hepatitis C Virus And Therapeutic...nities ,, http://www.reportlinker.com/p016427...date-of-Market-Trends--Opportunities.html ,, B...meager clinical outcomes owing to lack of superior...
(Date:12/2/2009).... 2 Jupiter Medical Cen...agnostic tools available into its imaging program,...are. The system delivers highly detailed images of...ution and unique applications, including dual brea...patients with renal dysfunction. This results in ...
Breaking Medicine Technology:Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 2Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 3Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 4Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 5Reportlinker Adds Hepatitis C Virus and Therapeutics - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Hepatitis C Virus and Therapeutics - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Hepatitis C Virus and Therapeutics - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Hepatitis C Virus and Therapeutics - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Hepatitis C Virus and Therapeutics - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Hepatitis C Virus and Therapeutics - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Hepatitis C Virus and Therapeutics - A Global Update of Market Trends & Opportunities 8Jupiter Medical Center Announces New High-Definition MRI System 2Fight to Preserve Flexible Spending Accounts Moves to the House of Representatives 59453 1Fight to Preserve Flexible Spending Accounts Moves to the House of Representatives 59453 2Fight to Preserve Flexible Spending Accounts Moves to the House of Representatives 59453 3Healthy Advice Networks Now Able to Track Consumer Purchase Behavior 59449 1Healthy Advice Networks Now Able to Track Consumer Purchase Behavior 59449 2Healthy Advice Networks Now Able to Track Consumer Purchase Behavior 59449 3Increased success a virtual certainty for rugby players 59448 1Increased success a virtual certainty for rugby players 59448 2
...s, April 19, 2007 /PRNewswire/ -- New clinical,tri...eleased at the,upcoming International Society for ... Meeting and Scientific Sessions at the Hilton,San...e for efficacy,and safety of immunosuppression the... in heart transplants. , , Research to be prese...
... a Venous ThromboEmbolism (VTE) is Reduced by a,Si...eated With,Clexane(R) / Lovenox(R), BRIDGEWATER, N...fi-aventis announced the publication of the PREVAI...ith LMWH Enoxaparin) trial in,the April 21st issue...at once daily administration of Clexane(R) / Loven...
Other Medicine Technology:New Anti-Rejection Medication 6-Month Results for Heart Transplant,Recipients to Be Released at International Heart and Lung,Transplant Meeting 2The Lancet Publishes PREVAIL Study Results Showing Lovenox,Superiority Over Unfractionated Heparin for Reducing the Risk of,Venous ThromboEmbolism in Patients With Acute Ischemic Stroke 2The Lancet Publishes PREVAIL Study Results Showing Lovenox,Superiority Over Unfractionated Heparin for Reducing the Risk of,Venous ThromboEmbolism in Patients With Acute Ischemic Stroke 3The Lancet Publishes PREVAIL Study Results Showing Lovenox,Superiority Over Unfractionated Heparin for Reducing the Risk of,Venous ThromboEmbolism in Patients With Acute Ischemic Stroke 4The Lancet Publishes PREVAIL Study Results Showing Lovenox,Superiority Over Unfractionated Heparin for Reducing the Risk of,Venous ThromboEmbolism in Patients With Acute Ischemic Stroke 5The Lancet Publishes PREVAIL Study Results Showing Lovenox,Superiority Over Unfractionated Heparin for Reducing the Risk of,Venous ThromboEmbolism in Patients With Acute Ischemic Stroke 6
(Date:12/3/2009)...sk factors linked to diabetes, cardiovascular trou...News) -- Breast-feeding, even for just a couple o...f metabolic syndrome -- a dangerous cluster of hea...new study appearing online Dec. 3 in the journal ...-related (gestational) diabetes, breast-feeding be...
(Date:12/3/2009)...ctices, Protecting Donors, and Blood Safety Key Is...wswire/ -- Teamsters who work at American Red Cros...went on strike this morning to protest unfair labo...t these facilities that could imperil the safety o...t to mention the wellbeing of employees. ,, Th...
(Date:12/3/2009)...di Kessock receives President’s Service Awar...cember 2, 2009 -- CS3 Technology, a leading profes...tions to businesses across the country, is pleased...h year at their company-wide retreat, CS3 recogniz... This year, Cindi Kessock earned the President&rsq...
(Date:12/3/2009)...ent studies have shown that sleep deprivation can ...of obesity. Treadmill desks have been show effecti...sks while increasing the quality of sleep. , ..., 2009 -- Two sleep studies illustrating the negat...reached independent conclusions which ignore the r...
(Date:12/3/2009)...ightra Medical, Inc, a California based medical de... ventral hernia repair system. Freedom Ventral is ...hich completely obviates the need for complex, tim... (PRWEB) December 3, 2009 -- Insightra Medical,...day announced the launch of its new ventral hernia...
Breaking Medicine News(10 mins):Health News:Breast-Feeding Can Help Mom's Heart Decades Later 2Health News:Breast-Feeding Can Help Mom's Heart Decades Later 3Health News:Philadelphia Red Cross Blood Workers Strike to Protect Donor and Blood Safety 2Health News:CS3 Technology Announces Annual Employee Awards 2Health News:CS3 Technology Announces Annual Employee Awards 3Health News:Treadmill Desks Lower Health Risks Caused by Lack of Sleep 2Health News:Insightra Medical Launches the Freedom(TM) Ventral Hernia Repair, an Innovative New Way to Deploy Sublay Implants for Ventral Hernias Without Suturing 2Health News:Insightra Medical Launches the Freedom(TM) Ventral Hernia Repair, an Innovative New Way to Deploy Sublay Implants for Ventral Hernias Without Suturing 3Health News:Insightra Medical Launches the Freedom(TM) Ventral Hernia Repair, an Innovative New Way to Deploy Sublay Implants for Ventral Hernias Without Suturing 4
...ntaining two drugs may be the key when it comes to...with even moderate hypertension. The inter...scular Events through Combination Therapy in Patie... As part of the study, researchers examined 10,70...
... College London refutes the long-standing "runaway...ability to fight infection by attacking T helper c...e the immune defences. Scientists have for...cells infected by HIV produce more HIV virus parti...
...rchers have found that macrophages, the scavenger ...emakers for their role in obesity, may sometimes b...ng is based on a study that highlights the benefic...und that they can also do good things," Nature mag...
...f virgin birth in cartilaginous fish, after bustin...an aquarium, that had only female sharks which ha... The birth of the pup at Omaha's Henry Doorly...e sharks have an organ that can store sperm, but a...
...nd with tuberculosis in the Chambal region of Madh...ries because they get no other jobs, constant expo... of getting TB. Saharia tribals and backwa.... The benefits of the Revised National Tub...
...ies, Lions Club of Calcutta will reach out to more...ilee year. "All the three healthcare units...d by the patients. We have now set a target to rea...sday. "We have also made a plan to develop...
Other Medicine News:Health News:Single-tablet With Two Drugs may Help Control High BP Better 2Health News:Study Refutes Theory on HIV's Effect on White Blood Cells 2Health News:Macrophages may Help Prevent Obesity 2Health News:Miners in Madhya Pradesh at High Risk of Developing TB 2
...her and ergonomically designed for ease of handlin...ed. The pipette mount rubber is made of silicone a... dosing to be carried out when filling and emptyin... Each PipetBoy comes complete with: power supply-I...
Eppendorf Pipet Helper
Single Pipette Hanger
Focus Carousel Stand
Medicine Products: